NSE filing, NSE: ANONDITA. Summary written from the filing by ALFA Finder's alert engine.
Anondita Medicare Ltd: key numbers
- Share price
- ₹1,000.00
- Market cap
- ₹1,904 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 56.9×Sector 38.6×
- Promoter holding
- 59.26%
- FII holding
- 2.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Ltd
All →Anondita Medicare Annual General Meeting
Anondita Medicare Limited reported the proceedings of its 3rd Annual General Meeting held on September 29, 2026, where several ordinary and special businesses were discussed.
Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr
Anondita Medicare Other Announcement
Anondita Medicare Limited clarified procedures for handling odd lots of Rights Entitlements and shares during its ongoing Rights Issue. No new transaction value is involved.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.
Anondita Medicare Announces New Order Win
Anondita Medicare Limited has been declared the L1 bidder by the Central Medical Services Society for supplying 8.01 crore pieces of condoms.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.